Nuritas to triple Irish headcount
Digital biotechnology and research company Nuritas is to triple the headcount at its Irish headquarters to more than 60 in 2017.
The company also confirmed U2’s Bono and The Edge as investors in the company. Bono and The Edge recently visited Nuritas’ offices in Dublin to mark the announcement of the Irish expansion as well as further growth of its US-based operations.
The additions to its workforce will include roles across R&D, business development and other key support functions. Nuritas will continue to base its headquarters in Ireland but also plans new hires and expansion of its US operations following on from the recent opening of its first US office in San Francisco in 2016.
The announcement comes after Nuritas’ recent award of €3 million in EU and associated funding to help bring to market a breakthrough food ingredient, considered a potential world-first in diabetes prevention, for which clinical trials are commencing shortly.
Founded in 2014 by mathematician and computational biologist Dr Nora Khaldi, Nuritas uses artificial intelligence, deep learning and DNA analysis to predict and provide access to components hidden within food called peptides that can manage and improve human health.
Speaking at Nuritas’ Dublin headquarters, The Edge said: “When we first started talking with Nuritas, I was blown away with how their ideas could be used to significantly improve the health of billions of people globally. Using cutting-edge technology and really smart approaches to identify disease-beating peptides in food is something that has never been done before.”
Dr Khaldi added: “We aim high and think outside the box at Nuritas which is something that Bono and the Edge have done throughout their careers. We are delighted to have them join the Nuritas family and embrace our mission of improving the health of billions of people around the world.”